1st Quarter - Report

THE DUBERSTEIN GROUP INC. for AMGEN INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

General trade issues.

LobbyistCovered position, as disclosed
STEVEN CHAMPLIN —

Contacted: HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Corporate tax issues, including repatriation.

LobbyistCovered position, as disclosed
KENNETH DUBERSTEIN —
DANIEL P MEYER —

Contacted: HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Sustainable growth rate - HR 1470, SGR Repeal and Medicare Provider Payment Modernization Act of 2015; S 810, SGR Repeal and Medicare Provider Payment Modernization Act of 2015; HR 2, Medicare Access and CHIP Reauthorization Act of 2015.

LobbyistCovered position, as disclosed
DANIEL P MEYER —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 1470 (114th), H.R. 2 (114th)

Health Issues HCR

21st Century Cures - Proposed legislation. Health reform options.

LobbyistCovered position, as disclosed
KENNETH DUBERSTEIN —
DANIEL P MEYER —

Contacted: HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.